Facebook Instagram Pinterest Reddit Tumblr X Youtube
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 201

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Breaking: Helus’ Deuterated Psilocin Hits Primary Endpoint in First Phase 3

Podcast: Compass Files Psilocybin Application with FDA, U.S. Government Taps Mark Cuban to Develop Ibogaine, Psychedelics After the Midterms

Field Notes #6: Dispatches from D.C. as Three Psychedelics Land at FDA

Breaking: U.S. Government Taps Mark Cuban’s Company to Develop Ibogaine for PTSD; Commits to Fund $20M Real-World Evidence Network

220 Patients or 20,000? Clinics Split on Psychedelics’ First Year

Entheon Biomedical Announces Non-Brokered Private Placement Financing

Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule...

MindMed Appoints Francois Lilienthal, MD as Chief Commercial Officer

Beckley Psytech Announces Dosing of First Healthy Volunteers in Phase 1...

PT307 – Kathryn L. Tucker, JD – The Right to Try...

Health Canada Approves First Special Access Program Requests for Psilocybin

Psychedelic Bulletin: Bizarre News from Across the Psychedelics Space (April 1,...

Canada’s SAP Expansion Signals a Step Forward for Psychedelics

PT306 – Dr. Devon Christie – Vital Psychedelic Conversations

Mydecine Reports Financial Results for the Fiscal Year 2021 and Provides...

Load more

EDITOR PICKS

Breaking: Helus’ Deuterated Psilocin Hits Primary Endpoint in First Phase 3

Podcast: Compass Files Psilocybin Application with FDA, U.S. Government Taps Mark...

Field Notes #6: Dispatches from D.C. as Three Psychedelics Land at...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    Facebook Instagram Pinterest Reddit Tumblr X Youtube
    ©